Articles published in Immunochemistry & Immunopathology have been cited by esteemed scholars and scientists all around the world.
Immunochemistry & Immunopathology has got h-index 7, which means every article in Immunochemistry & Immunopathology has got 7 average citations.
Following are the list of articles that have cited the articles published in Immunochemistry & Immunopathology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Total published articles | 60 | 36 | 30 | 3 | 4 | 2 | 4 | 
| Research, Review articles and Editorials | 0 | 3 | 5 | 0 | 4 | 2 | 4 | 
| Research communications, Review communications, Editorial communications, Case reports and Commentary | 50 | 33 | 25 | 0 | 0 | 0 | 0 | 
| Conference proceedings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 
| Citations received as per Google Scholar, other indexing platforms and portals | 185 | 139 | 50 | 17 | 26 | 24 | 22 | 
| Journal total citations count | 174 | 
| Journal impact factor | 1.33 | 
| Journal 5 years impact factor | 10.82 | 
| Journal cite score | 1.56 | 
| Journal h-index | 7 | 
| Journal h-index since 2019 | 5 | 
| Papillion, A., & Ballesteros-Tato, A. (2021). The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses. Frontiers in Immunology, 12. | |
| Paquissi, F. C., & Abensur, H. (2021). The Th17/IL-17 Axis and Kidney diseases, with focus on Lupus Nephritis. Frontiers in Medicine, 1432. | |
| Oon, S. (2017). IL-3R? as a novel therapeutic target in systemic lupus erythematosus (Doctoral dissertation). | |
| Saleh, R. A. (2017). Pro-inflammatory mediators in arthritic pain and disease (Doctoral dissertation). | |
| Lee, M. H. (2019). Modulators of Dendritic Cells and B Cells in Lupus. Temple University. | |
| Yoon, T., Ahn, S. S., Pyo, J. Y., Lee, L. E., Song, J. J., Park, Y. B., & Lee, S. W. (2021). Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Mediators of Inflammation, 2021. | |
| Pawlak-Bu?, K., Schmidt, W., & Leszczy?ski, P. (2021). Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus. Journal of clinical medicine, 10(20), 4788. | |
| Acharya, B., & Moudgil, K. D. (2015). IL-27-induced modulation of autoimmunity and its therapeutic potential. | |
| Abd ElGlil, R. R., Emam, S. M., & Hashaad, N. I. (2015). Expression of IL-23 mRNA in systemic lupus erythramtosus patients: Relation with disease Activity. EGYPTIAN JOURNAL OF IMMUNOLOGY, 22(2), 09-21. | |
| Vázquez-Vázquez, Christian, Rosalinda Posadas-Sánchez, Nonanzit Pérez-Hernández, José Manuel Rodríguez-Pérez, José Manuel Fragoso, Guillermo Cardoso-Saldana, and Gilberto Vargas-Alarcón. "The rs2066808 polymorphism located near the IL-23A gene is associated with premature coronary artery disease in Mexican population (GEA study)." DNA and cell biology 38, no. 8 (2019): 880-886. | |
| Vázquez-Vázquez, C., Posadas-Sánchez, R., Fragoso, J. M., Ramírez-Bello, J., Sánchez-Guerra, M., Osorio-Yañez, C., & Vargas-Alarcón, G. (2020). IL-12B Polymorphisms Are Associated with the Presence of Premature Coronary Artery Disease and with Cardiovascular Risk Factors: The Genetics of Atherosclerotic Disease Mexican Study. DNA and cell biology, 39(7), 1347-1355. | |
| Rezaeepoor, M., Hoseini-Aghdam, M., Sheikh, V., Eftekharian, M. M., & Behzad, M. (2020). Evaluation of Interleukin-23 and JAKs/STATs/SOCSs/ROR-?t Expression in Type 2 Diabetes Mellitus Patients Treated With or Without Sitagliptin. Journal of Interferon & Cytokine Research, 40(11), 515-523. | |
| Coppock, G. M., Aronson, L. R., Park, J., Qiu, C., Park, J., DeLong, J. H., ... & Hunter, C. A. (2020). Loss of IL-27R? results in enhanced tubulointerstitial fibrosis associated with elevated th17 responses. The Journal of Immunology, 205(2), 377-386. | |
| Hassan, A. S., Abdel-Mohsen, M. M., Zakria, D. M., Zakaria, Z. M., & Althoqapy, A. A. (2018). Association of interleukin 23 and anti-ficolin-2 antibodies with lupus nephritis. American Journal of Biochemistry, 8(2), 19-29. | |
| Vukelic, Milena, Anita Laloo, and Vasileios C. Kyttaris. "Interleukin 23 is elevated in the serum of patients with SLE." Lupus 29.14 (2020): 1943-1947. | |
| Rivadeneyra-Burgos, C., Rodríguez-Montaño, R., del Carmen Ruiz-Gutiérrez, A., del Carmen Martínez-Rodríguez, V., Meléndez-Ruiz, J. L., Pita-López, M. L., ... & Guerrero-Velázquez, C. (2017). Determinación de los niveles del receptor soluble de IL-23 en suero y plasma de pacientes con periodontitis crónica y agresiva. Revista Mexicana de Periodontología, 8(1), 5-10. | |
| Miteva, L. D., Manolova, I. M., Ivanova, M. G., Stoilov, R. M., & Stanilova, S. A. (2020). High interleukin-18 and low FOXP3 mRNAs in peripheral blood of women with severe systemic lupus erythematosus: a cross-sectional study. Rheumatology international, 40(5), 727-735. | |
| Beizavi, Z., Zohouri, M., Asadipour, M., & Ghaderi, A. (2021). IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. International Reviews of Immunology, 40(5), 319-329. | |
| Lee, M. H., Gallo, P. M., Hooper, K. M., Corradetti, C., Ganea, D., Caricchio, R., & Gallucci, S. (2019). The cytokine network type I IFN?IL?27?IL?10 is augmented in murine and human lupus. Journal of leukocyte biology, 106(4), 967-975. | |
Immunochemistry & Immunopathology received 174 citations as per Google Scholar report